CY1108280T1 - Basb205 πολυπεπτιδια και πολυνουκλεοτιδια που τα κωδικοποιουν - Google Patents

Basb205 πολυπεπτιδια και πολυνουκλεοτιδια που τα κωδικοποιουν

Info

Publication number
CY1108280T1
CY1108280T1 CY20081100894T CY081100894T CY1108280T1 CY 1108280 T1 CY1108280 T1 CY 1108280T1 CY 20081100894 T CY20081100894 T CY 20081100894T CY 081100894 T CY081100894 T CY 081100894T CY 1108280 T1 CY1108280 T1 CY 1108280T1
Authority
CY
Cyprus
Prior art keywords
polynucleotides encoding
polypeptides
basb205
basb205 polypeptides
prophylactic
Prior art date
Application number
CY20081100894T
Other languages
English (en)
Inventor
Joelle Thonnard
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of CY1108280T1 publication Critical patent/CY1108280T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η εφεύρεση παρέχει BASB205 πολυπεπτίδια και πολυνουκλεοτίδια που κωδικοποιούν BASB205 πολυπεπτίδια και μεθόδους παραγωγής τέτοιων πολυπεπτιδίων με τεχνικές ανασυδυασμού. Επίσης παρέχονται διαγνωστικές προφυλακτικές και θεραπευτικές χρήσεις.
CY20081100894T 2000-10-13 2008-08-21 Basb205 πολυπεπτιδια και πολυνουκλεοτιδια που τα κωδικοποιουν CY1108280T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0025171.0A GB0025171D0 (en) 2000-10-13 2000-10-13 Novel compounds
EP01976280A EP1326982B1 (en) 2000-10-13 2001-10-05 Basb205 polypeptides and polynucleotides coding therefor

Publications (1)

Publication Number Publication Date
CY1108280T1 true CY1108280T1 (el) 2014-02-12

Family

ID=9901255

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100894T CY1108280T1 (el) 2000-10-13 2008-08-21 Basb205 πολυπεπτιδια και πολυνουκλεοτιδια που τα κωδικοποιουν

Country Status (12)

Country Link
US (2) US7838003B2 (el)
EP (2) EP1847609A1 (el)
AT (1) ATE397069T1 (el)
AU (1) AU2001295599A1 (el)
CA (1) CA2424938A1 (el)
CY (1) CY1108280T1 (el)
DE (1) DE60134253D1 (el)
DK (1) DK1326982T3 (el)
ES (1) ES2305111T3 (el)
GB (1) GB0025171D0 (el)
PT (1) PT1326982E (el)
WO (1) WO2002030971A2 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808866D0 (en) * 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
GB0025171D0 (en) * 2000-10-13 2000-11-29 Smithkline Beecham Biolog Novel compounds
CA2636566C (en) 2006-01-17 2018-03-13 Arne Forsgren A novel surface exposed haemophilus influenzae protein (protein e; pe)
US20150079132A1 (en) * 2013-09-17 2015-03-19 Path Evoking protection against streptotoccus pneumoniae incorporating b-cell and t-cell pneumococcal protein antigens and pneumococcal polysaccharides delivered concomitantly
JP2021534761A (ja) * 2018-08-23 2021-12-16 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性タンパク質および組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE466259B (sv) * 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
US5556755A (en) * 1993-09-29 1996-09-17 The Research Foundation Of State University Of New York Method for detecting Branhamella catarrhalis
CA2218741A1 (en) 1995-04-21 1996-10-24 Human Genome Sciences, Inc. Nucleotide sequence of the haemophilus influenzae rd genome, fragments thereof, and uses thereof
GB0025170D0 (en) * 2000-10-13 2000-11-29 Smithkline Beecham Biolog Novel compounds
GB0025171D0 (en) * 2000-10-13 2000-11-29 Smithkline Beecham Biolog Novel compounds
GB0025998D0 (en) * 2000-10-24 2000-12-13 Smithkline Beecham Biolog Novel compounds
WO2002088361A2 (en) * 2001-04-30 2002-11-07 Glaxosmithkline Biologicals S.A. Haemophilus influenzae antigens

Also Published As

Publication number Publication date
ATE397069T1 (de) 2008-06-15
EP1326982A2 (en) 2003-07-16
CA2424938A1 (en) 2002-04-18
ES2305111T3 (es) 2008-11-01
DE60134253D1 (de) 2008-07-10
WO2002030971A3 (en) 2002-11-07
US20110129475A1 (en) 2011-06-02
US7838003B2 (en) 2010-11-23
AU2001295599A1 (en) 2002-04-22
GB0025171D0 (en) 2000-11-29
WO2002030971A2 (en) 2002-04-18
PT1326982E (pt) 2008-08-13
DK1326982T3 (da) 2008-09-29
EP1326982B1 (en) 2008-05-28
US20040022803A1 (en) 2004-02-05
EP1847609A1 (en) 2007-10-24

Similar Documents

Publication Publication Date Title
GB9810276D0 (en) Novel compounds
WO1999058562A3 (en) Novel compounds
CY1108280T1 (el) Basb205 πολυπεπτιδια και πολυνουκλεοτιδια που τα κωδικοποιουν
GB9820003D0 (en) Novel compounds
AU3164600A (en) Novel compounds
GB9809683D0 (en) Novel compounds
GB9810285D0 (en) Novel compounds
GB9812163D0 (en) Novel compounds
GB0025170D0 (en) Novel compounds
AU4567300A (en) Novel compounds
GB9918208D0 (en) Novel compounds
AU1580300A (en) Novel compounds
WO2002034772A3 (en) Novel compounds
GB9918302D0 (en) Novel compounds
GB9918003D0 (en) Novel compounds
GB0025169D0 (en) Novel compounds
GB9918206D0 (en) Novel compounds
WO2002066503A3 (en) H. influenzae antigen basb213
GB9918281D0 (en) Novel compounds
GB9914945D0 (en) Novel compounds
AU1383901A (en) Novel compounds